Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Christopher D. Conrady, Cagri G. Besirli, Caroline R. Baumal, Jaclyn L. Kovach, Justin D. Etzel, Jonathan C. Tsui, Susan G. Elner & Mark W. Johnson. (2022) Ocular Toxoplasmosis after Exposure to Wild Game. Ocular Immunology and Inflammation 30:3, pages 527-532.
Read now
Read now
Maarten M Bruin, Ruud L M Deijkers, Roos Bazuin, Erika P M Elzakker & Bart G Pijls. (2021) Proton-pump inhibitors are associated with increased risk of prosthetic joint infection in patients with total hip arthroplasty: a case-cohort study. Acta Orthopaedica 92:4, pages 431-435.
Read now
Read now
Shu-Juan Zhou, Si-Qian Wang, Yong-Yong Ma, Li-Yuan Tang, Yi-Fen Shi, Bin Liang, Yi Chen & Kang Yu. (2016) Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy. Hematology 21:6, pages 332-337.
Read now
Read now
Angela Vassallo, Mai-Chi N Tran & Ellie JC Goldstein. (2014) Clostridium difficile: improving the prevention paradigm in healthcare settings. Expert Review of Anti-infective Therapy 12:9, pages 1087-1102.
Read now
Read now
Prabath G. Biju, Igor Gubrij, Sarita Garg, Prem K. Gupta, Martin Hauer-Jensen & Alexander F. Burnett. (2014) Radiation lethality potentiation in total body irradiated mice by a commonly prescribed proton pump inhibitor, Pantoprazole sodium. International Journal of Radiation Biology 90:7, pages 554-559.
Read now
Read now
Bikash Medhi & Ajay Prakash. (2008) Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice. Scandinavian Journal of Gastroenterology 43:8, pages 1022-1023.
Read now
Read now
Marta Maróstica, Demetrius Paiva Arçari, Waldemar Bartchewsky$suffix/text()$suffix/text(), Miriam Trevisan, Marcelo Lima Ribeiro, José Pedrazzoli$suffix/text()$suffix/text(), Nelci Fenalti Hoehr & Alessandra Gambero. (2007) Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice. Scandinavian Journal of Gastroenterology 42:12, pages 1404-1412.
Read now
Read now
Angelo De Milito & Stefano Fais. (2005) Proton pump inhibitors may reduce tumour resistance. Expert Opinion on Pharmacotherapy 6:7, pages 1049-1054.
Read now
Read now
Articles from other publishers (54)
Christopher D. Conrady, Tejus Pradeep, Yinxi Yu, Mark W. Johnson & Brian L. VanderBeek. (2023) Association of Proton Pump Inhibitor/Histamine-2 Blocker Use and Ocular Toxoplasmosis. Ophthalmology Retina 7:3, pages 261-265.
Crossref
Crossref
Isabelle Goyer, Edouard Lacotte, Julien Montreuil, Pascal Thibon, Anaïs R. Briant, Claire Dupont, Jean-Jacques Parienti & David Brossier. (2022) Proton Pump Inhibitor Use and Associated Infectious Complications in the PICU: Propensity Score Matching Analysis. Pediatric Critical Care Medicine 23:12, pages e590-e594.
Crossref
Crossref
Syeda Sahra, Mohammad Abureesh, Shivantha Amarnath, Motasem Alkhayyat, Rawan Badran, Abdullah Jahangir & Vivek Gumaste. (2021)
Clostridioides difficile
infection in liver cirrhosis patients: A population-based study in United States
. World Journal of Hepatology 13:8, pages 926-938.
Crossref
Crossref
Henning Sommermeyer & Jacek PiątekHenning Sommermeyer & Jacek Piątek. 2021. Clostridioides difficile. Clostridioides difficile
49
59
.
Andrea Corsonello & Fabrizia Lattanzio. (2019) Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?. Trends in Cardiovascular Medicine 29:6, pages 353-360.
Crossref
Crossref
Felicia D. Allard & Edward B. Stelow. (2019) Review of Drug-induced Injury in Mucosal Biopsies From the Tubular Gastrointestinal Tract. Advances in Anatomic Pathology 26:3, pages 151-170.
Crossref
Crossref
Sophie Ribiere, Marie-Anne Guillaumot, Amélie Barré, Einas Abou Ali, Maximilien Barret, Stanislas Chaussade & Romain Coriat. (2019) Quel est le VRAI risque au long cours des inhibiteurs de la pompe à protons ?. La Presse Médicale 48:5, pages 503-510.
Crossref
Crossref
Abdel-Naser Elzouki, Nadia Neffati, Fatma A. Rasoul, Ali Abdallah, Muftah Othman & Abdelkarim Waness. (2019) Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors. GE - Portuguese Journal of Gastroenterology 26:2, pages 83-89.
Crossref
Crossref
Wei-Te Hung, Ying-Hock Teng, Shun-Fa Yang, Han-Wei Yeh, Ying-Tung Yeh, Yu-Hsun Wang, Ming-Yung Chou, Ming-Chih Chou, Chi-Ho Chan & Chao-Bin Yeh. (2018) Association between Proton Pump Inhibitor Use and CNS Infection Risk: A Retrospective Cohort Study. Journal of Clinical Medicine 7:9, pages 252.
Crossref
Crossref
Yohannes T. Ghebre. (2018) Proton Pump Inhibitors in IPF: A Call for Clinical Trials. Frontiers in Pharmacology 9.
Crossref
Crossref
Carolin Maria Haas, Martina Maywald, Andreas Goetzenich, Christian Stoppe & Lothar Rink. (2018) Proton-pump inhibitors elevate infection rate in cardiothoracic surgery patients by influencing PMN function in vitro and in vivo. Journal of Leukocyte Biology 103:4, pages 777-788.
Crossref
Crossref
D. Bettinger, D. Martin, S. Rieg, M. Schultheiss, N. Buettner, R. Thimme & T. Boettler. (2018) Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess. Alimentary Pharmacology & Therapeutics 47:6, pages 801-808.
Crossref
Crossref
Maja Kostrzewska, Agnieszka Świdnicka-Siergiejko, Dorota Olszańska, Grażyna Jurkowska, Marzena Garley, Wioletta Ratajczak-Wrona, Ewa Jabłońska, Jacek Jamiołkowski & Andrzej Dabrowski. (2017) The effect of omeprazole treatment on the gut microflora and neutrophil function. Clinics and Research in Hepatology and Gastroenterology 41:5, pages 575-584.
Crossref
Crossref
Leon Fisher & Alexander Fisher. (2017) Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clinical Drug Investigation 37:7, pages 587-624.
Crossref
Crossref
Maja KostrzewskaMarzena GarleyWioletta Ratajczak-WronaEwa JabłońskaJacek JamiołkowskiAndrzej Dabrowski. (2017) The effect of short-term oral treatment with omeprazole or pantoprazole on the function of polymorphonuclear neutrophils. Canadian Journal of Physiology and Pharmacology 95:6, pages 675-680.
Crossref
Crossref
Carlos Carvajal, Carlos Pacheco & Fabián Jaimes. (2017) Clinical and demographic profile and risk factors for Clostridium difficile infection. Biomédica 37:1, pages 53.
Crossref
Crossref
Sarah Larcombe, Melanie L. Hutton & Dena Lyras. (2016) Involvement of Bacteria Other Than Clostridium difficile in Antibiotic-Associated Diarrhoea. Trends in Microbiology 24:6, pages 463-476.
Crossref
Crossref
Lukas Buendgens. (2016) Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis. World Journal of Critical Care Medicine 5:1, pages 57.
Crossref
Crossref
Chalermrat Bunchorntavakul, Naichaya Chamroonkul & Disaya Chavalitdhamrong. (2016) Bacterial infections in cirrhosis: A critical review and practical guidance. World Journal of Hepatology 8:6, pages 307.
Crossref
Crossref
Natasha Singh, Aparna Dhayade, Abdel-Latif Mohamed & Tejasvi Vasant Chaudhari. (2016) Morbidity and Mortality in Preterm Infants following Antacid Use: A Retrospective Audit. International Journal of Pediatrics 2016, pages 1-6.
Crossref
Crossref
Priscilla Johanesen, Kate Mackin, Melanie Hutton, Milena Awad, Sarah Larcombe, Jacob Amy & Dena Lyras. (2015) Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance. Genes 6:4, pages 1347-1360.
Crossref
Crossref
Yohannes T Ghebremariam, John P Cooke, William Gerhart, Carol Griego, Jeremy B Brower, Melanie Doyle-Eisele, Benjamin C Moeller, Qingtao Zhou, Lawrence Ho, Joao de Andrade, Ganesh Raghu, Leif Peterson, Andreana Rivera & Glenn D Rosen. (2015) Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis. Journal of Translational Medicine 13:1.
Crossref
Crossref
Cade M. Nylund, Matilda Eide & Gregory H. Gorman. (2014) Association of Clostridium difficile Infections with Acid Suppression Medications in Children. The Journal of Pediatrics 165:5, pages 979-984.e1.
Crossref
Crossref
Edaire Cheng, Rhonda F. Souza & Stuart Jon Spechler. (2014) Eosinophilic Esophagitis. Gastroenterology Clinics of North America 43:2, pages 243-256.
Crossref
Crossref
Daryl D. DePestel & David M. Aronoff. (2013)
Epidemiology of
Clostridium difficile
Infection
. Journal of Pharmacy Practice 26:5, pages 464-475.
Crossref
Crossref
Marie de Vos, Bénédicte De Vroey, Béatrice Garcia Garcia, Clothilde Roy, François Kidd, Jean Henrion & Pierre Deltenre. (2013) Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Liver International 33:9, pages 1316-1323.
Crossref
Crossref
Ethan A. Mezoff & Mitchell B. Cohen. (2013) Acid Suppression and the Risk of Clostridium difficile Infection. The Journal of Pediatrics 163:3, pages 627-630.
Crossref
Crossref
Edaire Cheng. (2013) Proton pump inhibitors for eosinophilic oesophagitis. Current Opinion in Gastroenterology 29:4, pages 416-420.
Crossref
Crossref
Béatrice Jans, Didier Schoevaerdts, Te-Din Huang, Catherine Berhin, Katrien Latour, Pierre Bogaerts, Claire Nonhoff, Olivier Denis, Boudewijn Catry & Youri Glupczynski. (2013) Epidemiology of Multidrug-Resistant Microorganisms among Nursing Home Residents in Belgium. PLoS ONE 8:5, pages e64908.
Crossref
Crossref
Yong Gil Kim & Byung Ik Jang. (2013) Significance of Proton Pump Inhibitor Types for Clostridium difficile Infection. Journal of Clinical Gastroenterology 47:3, pages 292.
Crossref
Crossref
Luigi Corvaglia, Caterina Monari, Silvia Martini, Arianna Aceti & Giacomo Faldella. (2013) Pharmacological Therapy of Gastroesophageal Reflux in Preterm Infants. Gastroenterology Research and Practice 2013, pages 1-12.
Crossref
Crossref
Ryan T. Hurt, Thomas H. Frazier, Stephen A. McClave, Neil E. Crittenden, Christopher Kulisek, Mohamed Saad & Glen A. Franklin. (2012) Stress Prophylaxis in Intensive Care Unit Patients and the Role of Enteral Nutrition. Journal of Parenteral and Enteral Nutrition 36:6, pages 721-731.
Crossref
Crossref
C. P. C. de Jager, P. C. Wever, E. F. A. Gemen, M. G. H. van Oijen, A. B. van Gageldonk‐Lafeber, P. D. Siersema, G. C. M. Kusters & R. J. F. Laheij. (2012)
Proton pump inhibitor therapy predisposes to community‐acquired
S
treptococcus pneumoniae
pneumonia
. Alimentary Pharmacology & Therapeutics 36:10, pages 941-949.
Crossref
Crossref
Chun Shing Kwok, Aaron Kobina Arthur, Chukwudubem Ifeanyichukwu Anibueze, Sonal Singh, Rodrigo Cavallazzi & Yoon Kong Loke. (2012) Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis. American Journal of Gastroenterology 107:7, pages 1011-1019.
Crossref
Crossref
Valerie A Potter & Aloysious Aravinthan. (2012)
Identifying patients at risk of severe
Clostridium difficile
–associated disease
. British Journal of Hospital Medicine 73:5, pages 265-270.
Crossref
Crossref
C. Bavishi & H. L. DuPont. (2011) Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Alimentary Pharmacology & Therapeutics 34:11-12, pages 1269-1281.
Crossref
Crossref
Halis Suleyman, Abdulmecit Albayrak, Mehmet Bilici, Elif Cadirci & Zekai Halici. (2010) Different Mechanisms in Formation and Prevention of Indomethacin-induced Gastric Ulcers. Inflammation 33:4, pages 224-234.
Crossref
Crossref
Jasmohan S Bajaj, Ashwin N Ananthakrishnan, Muhammad Hafeezullah, Yelena Zadvornova, Alexis Dye, Emily L McGinley, Kia Saeian, Douglas Heuman, Arun J Sanyal & Raymond G Hoffmann. (2010) Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center Perspective. American Journal of Gastroenterology 105:1, pages 106-113.
Crossref
Crossref
Ramalinga R. Kedika, Rhonda F. Souza & Stuart Jon Spechler. (2009) Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications. Digestive Diseases and Sciences 54:11, pages 2312-2317.
Crossref
Crossref
Sunghee Choi, Hyun Jung Min, Miyoung Kim, Eun Sook Hwang & Kyunglim Lee. (2009) Proton Pump Inhibitors Exert Anti-Allergic Effects by Reducing TCTP Secretion. PLoS ONE 4:6, pages e5732.
Crossref
Crossref
R. Colucci, M. Fornai, L. Antonioli, N. Ghisu, M. Tuccori, C. Blandizzi & M. Del Tacca. (2009) Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment. Digestive and Liver Disease 41:6, pages 395-405.
Crossref
Crossref
Sandra M. Dial. (2009) Proton Pump Inhibitor Use and Enteric Infections. American Journal of Gastroenterology 104, pages S10-S16.
Crossref
Crossref
M Sandra Dial. (2009) Proton Pump Inhibitor Use and Enteric Infections. The American Journal of Gastroenterology 104:S2, pages S10-S16.
Crossref
Crossref
Matteo Fornai, Rocchina Colucci, Luca Antonioli, Narcisa Ghisu, Marco Tuccori, Corrado Blandizzi & Mario Del Tacca. (2008) Effects of pantoprazole on ulcer healing delay associated with NSAID treatment. Naunyn-Schmiedeberg's Archives of Pharmacology 379:3, pages 305-313.
Crossref
Crossref
O. Pastoris, M. Verri, F. Boschi, O. Kastsiuchenka, B. Balestra, F. Pace, M. Tonini & G. Natale. (2008) Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin. Naunyn-Schmiedeberg's Archives of Pharmacology 378:4, pages 421-429.
Crossref
Crossref
Adrienne J. Lindblad & Cheryl A. Sadowski. (2008) The safety of proton pump inhibitors*. Canadian Pharmacists Journal 141:sp1, pages S19-S21.
Crossref
Crossref
Corrado Blandizzi, Marco Tuccori, Rocchina Colucci, Giovanni Gori, Matteo Fornai, Luca Antonioli, Narcisa Ghisu & Mario Del Tacca. (2008) Clinical Efficacy of Esomeprazole in the Prevention and Healing of Gastrointestinal Toxicity Associated with NSAIDs in Elderly Patients. Drugs & Aging 25:3, pages 197-208.
Crossref
Crossref
E. Capodicasa, P. Cornacchione, B. Natalini, A. Bartoli, S. Coaccioli, P. Marconi & L. Scaringi. (2008) Omeprazole Induces Apoptosis in Normal Human Polymorphonuclear Leucocytes. International Journal of Immunopathology and Pharmacology 21:1, pages 73-85.
Crossref
Crossref
Cristina Pozzoli, Alessandro Menozzi, Daniela Grandi, Elvira Solenghi, Maria C. Ossiprandi, Chiara Zullian, Simone Bertini, Giulia M. Cavestro & Gabriella Coruzzi. (2006) Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn-Schmiedeberg's Archives of Pharmacology 374:4, pages 283-291.
Crossref
Crossref
Angelo De MilitoStefano Fais. (2005) Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncology 1:6, pages 779-786.
Crossref
Crossref
M. Fornai, G. Natale, R. Colucci, M. Tuccori, G. Carazzina, L. Antonioli, S. Baldi, V. Lubrano, A. Abramo, C. Blandizzi & M. Del Tacca. (2005) Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. Naunyn-Schmiedeberg's Archives of Pharmacology 372:1, pages 79-87.
Crossref
Crossref
Corrado Blandizzi. (2005) Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World Journal of Gastroenterology 11:26, pages 4052.
Crossref
Crossref
Tagliane Liza Becker, Marta Maróstica, Marcelo Lima Ribeiro, Sérgio de Mendonça, Alessandra Gambero & José PedrazzoliJr.Jr.. (2004) Pantoprazole treatment does not invoke anti-inflammatory properties in vivo. International Immunopharmacology 4:8, pages 1051-1057.
Crossref
Crossref
Gianfranco Natale, Gloria Lazzeri, Valter Lubrano, Rocchina Colucci, Cristina Vassalle, Matteo Fornai, Corrado Blandizzi & Mario Del Tacca. (2004) Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicology and Applied Pharmacology 195:1, pages 62-72.
Crossref
Crossref